Concentrix (NASDAQ:CNXC – Get Free Report) updated its first quarter earnings guidance on Wednesday. The company provided earnings per share guidance of $2.49-2.64 for the period, compared to the consensus earnings per share estimate of $2.85. The company issued revenue guidance of $2.355-2.370 billion, compared to the consensus revenue estimate of $2.41 billion. Concentrix also updated its FY 2025 guidance to 11.180-11.770 EPS.
Concentrix Stock Up 2.1 %
NASDAQ CNXC opened at $47.47 on Thursday. The business has a fifty day moving average price of $43.25 and a two-hundred day moving average price of $55.04. The stock has a market capitalization of $3.08 billion, a PE ratio of 15.41, a PEG ratio of 0.60 and a beta of 0.63. Concentrix has a fifty-two week low of $36.28 and a fifty-two week high of $106.10. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.57 and a quick ratio of 1.57.
Concentrix (NASDAQ:CNXC – Get Free Report) last announced its quarterly earnings data on Wednesday, January 15th. The company reported $3.26 earnings per share for the quarter, topping the consensus estimate of $3.01 by $0.25. Concentrix had a return on equity of 16.57% and a net margin of 2.18%. The business had revenue of $2.45 billion during the quarter, compared to the consensus estimate of $2.44 billion. During the same period in the prior year, the company earned $3.36 EPS. Concentrix’s revenue for the quarter was up 9.7% on a year-over-year basis. Equities analysts expect that Concentrix will post 10.11 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Read Our Latest Research Report on Concentrix
About Concentrix
Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.
Featured Articles
- Five stocks we like better than Concentrix
- Pros And Cons Of Monthly Dividend Stocks
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- High Flyers: 3 Natural Gas Stocks for March 2022
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- 3 Warren Buffett Stocks to Buy Now
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.